MaryamFouladiMD

Pediatric Hematology & Oncology • Columbus, OH

Professor, Pediatrics, University of Cincinnati College of Medicine

Join to view full profile

Dr. Fouladi is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Fouladi's full profile

Already have an account?

Office
700 Children's Drive
Columbus, OH 43205
Phone+1 614-722-5758
Is this information wrong?

Education & Training

University of Oklahoma Health Sciences CenterFellowship, Pulmonary Disease and Critical Care Medicine, 1995 - 1998
University of Toronto Faculty of MedicineClass of 1991

Certifications & Licensure

OH State Medical License 2008 - 2025
TN State Medical License 1998 - 2008
American Board of Pediatrics Pediatric Hematology-Oncology

Awards, Honors, & Recognition

America's Top Doctors Castle Connolly, 2014
America's Top Doctors for Cancer Castle Connolly, 2013

Clinical Trials

Oxaliplatin in Treating Children With Recurrent or Refractory Medulloblastoma, Supratentorial Primitive Neuroectodermal Tumor, or Atypical Teratoid Rhabdoid Tumor Start of enrollment: 2002 Oct 01
Completed
Phase 2
FR901228 in Treating Children With Refractory or Recurrent Solid Tumors or Leukemia Start of enrollment: 2002 Sep 01
Completed
Phase 1
Tipifarnib in Treating Young Patients With Recurrent or Progressive High-Grade Glioma, Medulloblastoma, Primitive Neuroectodermal Tumor, or Brain Stem Glioma Start of enrollment: 2003 Nov 01
Completed
Phase 2
Lapatinib in Treating Young Patients With Recurrent or Refractory Central Nervous System Tumors Start of enrollment: 2004 Oct 01
Completed
Phase 1, Phase 2
Vorinostat With or Without Isotretinoin in Treating Young Patients With Recurrent or Refractory Solid Tumors, Lymphoma, or Leukemia Start of enrollment: 2005 Aug 01
Completed
Phase 1
MK0752 in Treating Young Patients With Recurrent or Refractory CNS Cancer Start of enrollment: 2008 Jul 01
Terminated
Phase 1
Vorinostat Combined With Isotretinoin and Chemotherapy in Treating Younger Patients With Embryonal Tumors of the Central Nervous System Start of enrollment: 2009 Feb 25
Completed
Phase 1
Cixutumumab and Temsirolimus in Treating Younger Patients With Solid Tumors That Have Recurred or Not Responded to Treatment Start of enrollment: 2009 Apr 01
Completed
Phase 1
A Study of Bevacizumab Therapy in Patients With Newly Diagnosed High-Grade Gliomas and Diffuse Intrinsic Pontine Gliomas Start of enrollment: 2009 May 01
Completed
Early Phase 1
Selumetinib in Treating Young Patients With Recurrent or Refractory Low Grade Glioma Start of enrollment: 2010 Apr 19
Active, not recruiting
Phase 1, Phase 2
MK2206 in Treating Younger Patients With Recurrent or Refractory Solid Tumors or Leukemia Start of enrollment: 2011 Jan 01
Completed
Phase 1
Vorinostat, Temozolomide, or Bevacizumab in Combination With Radiation Therapy Followed by Bevacizumab and Temozolomide in Young Patients With Newly Diagnosed High-Grade Glioma Start of enrollment: 2011 Jan 26
Completed
Phase 2, Phase 3
Veliparib, Radiation Therapy, and Temozolomide in Treating Younger Patients With Newly Diagnosed Diffuse Pontine Gliomas Start of enrollment: 2012 Feb 01
Completed
Phase 1, Phase 2
p28 in Treating Younger Patients With Recurrent or Progressive Central Nervous System Tumors Start of enrollment: 2013 Aug 01
Completed
Phase 1
Pomalidomide in Treating Younger Patients With Recurrent, Progressive, or Refractory Central Nervous System Tumors Start of enrollment: 2015 Jul 14
Completed
Phase 1
Panobinostat in Treating Younger Patients With Progressive Diffuse Intrinsic Pontine Glioma Start of enrollment: 2016 Apr 01
International Diffuse Intrinsic Pontine Glioma (DIPG)/Diffuse Midline Glioma (DMG) Registry and Repository Start of enrollment: 2012 Jun 01
Recruiting
ONC201 in Pediatric H3 K27M Gliomas Start of enrollment: 2018 Jan 29
Active, not recruiting
Phase 1
A Phase 1b Study of PTC596 in Children With Newly Diagnosed Diffuse Intrinsic Pontine Glioma and High Grade Glioma Start of enrollment: 2018 Aug 01
Active, not recruiting
Phase 1
A Pilot Study of Larotrectinib for Newly-Diagnosed High-Grade Glioma With NTRK Fusion Start of enrollment: 2021 Apr 08
Recruiting
Early Phase 1
A Study of BXQ-350 in Children With Newly Diagnosed Diffuse Intrinsic Pontine Glioma (DIPG) or Diffuse Midline Glioma (DMG) Start of enrollment: 2021 May 24
Recruiting
Phase 1
Join now to see all

Publications & Presentations

PubMed

2 citations
The Brain Tumor Segmentation (BraTS) Challenge 2023:.
Anahita Fathi Kazerooni, Nastaran Khalili, Xinyang Liu, Debanjan Haldar, Zhifan Jiang, Syed Muhammed Anwar, Jake Albrecht, Maruf Adewole, Udunna Anazodo, Hannah Anders...> ;Arxiv. 2024 Mar 8
Consensus framework for conducting phase I/II clinical trials for children, adolescents, and young adults with pediatric low-grade glioma: Guidelines established by th...
Sabine Mueller, Jason Fangusaro, Arzu Onar Thomas, Thomas S Jacques, Pratiti Bandopadhayay, Peter de Blank, Roger J Packer, Maryam Fouladi, Antoinette Schouten van Mee...> ;Neuro-Oncology. 2024 Mar 4
Prognostic factors for pediatric, adolescent, and young adult patients with non-DIPG grade 4 gliomas: a contemporary pooled institutional experience.
Jennifer K Matsui, Pamela K Allen, Haley K Perlow, Jason M Johnson, Arnold C Paulino, Mary Frances McAleer, Maryam Fouladi, David R Grosshans, Amol J Ghia, Jing Li, Wa...> ;Journal of Neuro-Oncology. 2023 Jul 1
1 citations
Phase II Randomized Trial of Lenalidomide in Children With Pilocytic Astrocytomas and Optic Pathway Gliomas: A Report From the Children's Oncology Group.
Katherine E Warren, Gilbert Vezina, Mark Krailo, Linda Springer, Allen Buxton, Cody J Peer, William D Figg, Chris William-Hughes, Sandy Kessel, Maryam Fouladi, Amar Ga...> ;Journal of Clinical Oncology. 2023 Jun 20
12 citations
Medulloblastoma in the Modern Era: Review of Contemporary Trials, Molecular Advances, and Updates in Management.
Margot A Lazow, Joshua D Palmer, Maryam Fouladi, Ralph Salloum> ;Neurotherapeutics. 2022 Oct 1
12 citations
Vorinostat and isotretinoin with chemotherapy in young children with embryonal brain tumors: A report from the Pediatric Brain Tumor Consortium (PBTC-026).
Sarah E S Leary, Lindsay Kilburn, J Russell Geyer, Mehmet Kocak, Jie Huang, Kyle S Smith, Jennifer Hadley, Ralph Ermoian, Tobey J MacDonald, Stewart Goldman, Peter Phi...> ;Neuro-Oncology. 2022 Jul 1
1 citations
Characteristics of children ≤36 months of age with DIPG: A report from the international DIPG registry.
Allison L Bartlett, Adam Lane, Brooklyn Chaney, Nancy Yanez Escorza, Katie Black, Anne Cochrane, Jane Minturn, Ute Bartels, Kathy Warren, Jordan Hansford, David Ziegle...> ;Neuro-Oncology. 2022 Dec 1
6 citations
A Phase 2 Trial of Response-Based Radiation Therapy for Localized Central Nervous System Germ Cell Tumors: Patterns of Failure and Radiation Dosimetry for Nongerminoma...
Erin S Murphy, Girish Dhall, Jason Fangusaro, Ute Bartels, Maryam Fouladi, Dennis Shaw, Soumen Khatua, Chris Williams Hughes, Ashok Panigraphy, Myrsini Ioakeim-Ioannid...> ;International Journal of Radiation Oncology, Biology, Physics. 2022 May 1
2 citations
Imaging response assessment for CNS germ cell tumours: consensus recommendations from the European Society for Paediatric Oncology Brain Tumour Group and North America...
Giovanni Morana, Dennis Shaw, Shannon M MacDonald, Claire Alapetite, Thankamma Ajithkumar, Aashim Bhatia, Hervé Brisse, Camilo Jaimes, Thomas Czech, Girish Dhall, Jaso...> ;The Lancet. Oncology. 2022 May 1
4 citations
Phase I study of ribociclib and everolimus in children with newly diagnosed DIPG and high-grade glioma: A CONNECT pediatric neuro-oncology consortium report.
Mariko DeWire, Margot Lazow, Olivia Campagne, James Leach, Christine Fuller, Shiva Senthil Kumar, Joseph Stanek, Peter de Blank, Trent R Hummel, Natasha Pillay-Smiley,...> ;Neuro-Oncology Advances. 2022 Apr 16
1 citations
Corrigendum to: LTBK-01. Updates On The Phase Ii And Re-treatment Study Of AZD6244 (Selumetinib) For Children With Recurrent Or Refractory Pediatric Low Grade Glioma: ...
Jason R Fangusaro, Arzu Onar-Thomas, Tina Young Poussaint, Shengjie Wu, Azra H Ligon, Neal Ian Lindeman, Anuradha Banerjee, Roger Packer, Lindsay B Kilburn, Ian F Poll...> ;Neuro-Oncology. 2022 Aug 1
3 citations
Volumetric endpoints in diffuse intrinsic pontine glioma: comparison to cross-sectional measures and outcome correlations in the International DIPG/DMG Registry.
Margot A Lazow, Martijn T Nievelstein, Adam Lane, Pratiti Bandopadhayhay, Mariko DeWire-Schottmiller, Maryam Fouladi, John W Glod, Robert J Greiner, Lindsey M Hoffman,...> ;Neuro-Oncology. 2022 Sep 1
8 citations
Risk of secondary malignant neoplasms in children following proton therapy vs. photon therapy for primary CNS tumors: A systematic review and meta-analysis.
Rituraj Upadhyay, Divya Yadav, Bhanu P Venkatesulu, Raj Singh, Sujith Baliga, Raju R Raval, Margot A Lazow, Ralph Salloum, Maryam Fouladi, Elaine R Mardis, Nicholas G ...> ;Frontiers in Oncology. 2022 Jan 1
4 citations
Phase II Trial of Response-Based Radiation Therapy for Patients with Localized Germinoma: A Children's Oncology Group Study.
Ute Bartels, Arzu Onar-Thomas, Sunita K. Patel, Dennis Shaw, Jason Fangusaro, Girish Dhall, Mark M. Souweidane, Aashim Bhatia, Leanne Embry, Christine L. Trask, Erin S...> ;Neuro-Oncology. 2021 Nov 29
Machine Learning-Based Prediction of Survival Outcome in Lower Grade Gliomas With Combined Clinical and DNA Methylation Data.
N. Mladkova, Pierre Giglio, R. Salloum, Maryam Fouladi, Joshua D. Palmer> ;International Journal of Radiation Oncology Biology Physics. 2021 Nov 1
7 citations
Accuracy of Central Neuro-Imaging Review of DIPG Compared with Histopathology in the International DIPG Registry.
Margot A Lazow, Christine E. Fuller, Mariko DeWire, Adam Lane, Pratiti Bandopadhayay, Ute Bartels, Eric Bouffet, Sylvia Cheng, Kenneth J. Cohen, Tabitha Cooney, Scott ...> ;Neuro-Oncology. 2021 Oct 20
10 citations
Clinical phenotypes and prognostic features of embryonal tumours with multi-layered rosettes: a Rare Brain Tumor Registry study
Sara Khan, Palma Solano-Paez, Tannu Suwal, Mei Lu, Salma Al-Karmi, Ben Ho, Iqra Mumal, Mary Shago, Lindsey Hoffman, Andrew Dodgshun, Sumihito Nobusawa, Uri Tabori, Ute...> ;The Lancet. Child & Adolescent Health. 2021 Sep 29
20 citations
Phase 1/2 Trial of Vorinostat and Radiation and Maintenance Vorinostat in Children with Diffuse Intrinsic Pontine Glioma: A Children's Oncology Group Report.
Jack Su, Lindsay Kilburn, David B Mansur, Mark Krailo, Allen Buxton, Adesina Adekunle, Amar Gajjar, Peter C Adamson, Brenda J. Weigel, Elizabeth Fox, Susan M. Blaney, ...> ;Neuro-Oncology. 2021 Aug 4
50 citations
Efficacy of Carboplatin and Isotretinoin in Children With High-risk Medulloblastoma: A Randomized Clinical Trial From the Children's Oncology Group.
Sarah Leary, Roger J. Packer, Yimei Li, Catherine A. Billups, Kyle S. Smith, Alok Jaju, Linda Heier, Peter C. Burger, Karin S. Walsh, Yuanyuan Han, Leanne Embry, Jenni...> ;JAMA Oncology. 2021 Jul 22
68 citations
Children's Oncology Group Phase III Trial of Reduced-Dose and Reduced-Volume Radiotherapy With Chemotherapy for Newly Diagnosed Average-Risk Medulloblastoma
Jeff M. Michalski, Anna J. Janss, L. Gilbert Vezina, Kyle S. Smith, Catherine A. Billups, Peter C. Burger, Leanne Embry, Patricia Cullen, Kristina K. Hardy, Scott L. P...> ;Journal of Clinical Oncology. 2021 Jun 10
3 citations
Extraneural Metastases of Diffuse Midline Glioma, H3 K27M-Mutant at Diagnosis: Case Report, Review of the Literature, and Identifying Targetable Alterations.
Margot A Lazow, James L. Leach, Andrew T. Trout, John C. Breneman, Maryam Fouladi, Christine E. Fuller> ;Journal of Pediatric Hematology/oncology. 2021 May 11
21 citations
Temozolomide with irinotecan versus temozolomide, irinotecan plus bevacizumab for recurrent medulloblastoma of childhood: Report of a COG randomized Phase II screening...
Adam S. Levy, Mark Krailo, Susan N. Chi, Doojduen Villaluna, Linda Springer, Chris Williams-Hughes, Maryam Fouladi, Amar Gajjar> ;Pediatric Blood & Cancer. 2021 Apr 12
25 citations
Integrated molecular and clinical analysis of low-grade gliomas in children with neurofibromatosis type 1 (NF1).
Michael Fisher, David T.W. Jones, Yimei Li, Xiaofan Guo, Poonam Sonawane, Angela J. Waanders, Joanna J. Phillips, William A. Weiss, Adam C. Resnick, Sara J. C. Gosline...> ;Acta Neuropathologica. 2021 Feb 14
9 citations
A Phase I and Surgical Study of Ribociclib and Everolimus in Children with Recurrent or Refractory Malignant Brain Tumors: A Pediatric Brain Tumor Consortium Study.
Mariko DeWire, Christine Fuller, Olivia Campagne, Tong Lin, Haitao Pan, Tina Young Poussaint, Patricia Baxter, Eugene Hwang, Andrew Bukowinski, Kathleen Dorris, Lindse...> ;Clinical Cancer Research. 2021 Feb 5
3 citations
OLIG2 maintenance is not essential for diffuse intrinsic pontine glioma cell line growth but regulates tumor phenotypes.
Yunfei Liao, Zaili Luo, Yaqi Deng, Feng Zhang, Rohit Rao, Jiajia Wang, Lingli Xu, Shiva Senthil Kumar, Satarupa Sengupta, Mariko DeWire-Schottmiller, Kalen P. Berry, M...> ;Neuro-Oncology. 2021 Jul 1
Join now to see all

Journal Articles

International Experience in the Development of Patient-Derived Xenograft Models of Diffuse Intrinsic Pontine Glioma
Michelle Monje, Maryam Fouladi, Journal of Neuro-Oncology
Correction to: A Suggestion to Introduce the Diagnosis of “Diffuse Midline Glioma of the Pons, H3 K27 Wildtype (WHO Grade IV)”
Lindsey M Hoffman, Maryam Fouladi, Acta Neuropathologica

Press Mentions

NCI Launches Program to Offer Molecular Characterization of Childhood CancersMarch 21st, 2022
Radiation Therapy After Surgery for Pediatric EpendymomaApril 25th, 2019
Radiation After Surgery Triples Survival for a Type of Pediatric Brain TumorMarch 15th, 2019
Join now to see all